Short-term effects of catheter-based renal denervation on cardiac sympathetic drive and cardiac baroreflex function in heart failure

International Journal of Cardiology

Volumn 190, Issue 1, 2015, Pages 220-226

  Booth, Lindsea C ^a   Schlaich, Markus P ^b   Nishi, Erika E ^a,c   Yao, Song T ^a   Xu, Jianzhong ^b,d   Ramchandra, Rohit ^a,e   Lambert, Gavin W ^b   May, Clive N ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Animal model; Arterial baroreflex; Cardiac sympathetic nerve activity; Radiofrequency ablation; Renal denervation

Indexed keywords

NORADRENALIN; RENIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CATHETER; CATHETER BASED RENAL DENERVATION; CONTROLLED STUDY; EWE; FEMALE; HEART FAILURE; HEART INNERVATION; HEART RATE; KIDNEY DENERVATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RESTING HEART RATE; SYMPATHETIC INNERVATION; SYMPATHETIC TONE; THERAPY EFFECT; ANIMAL; CATHETERIZATION; INNERVATION; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SHEEP; SYMPATHECTOMY; TIME; TREATMENT OUTCOME;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; CATHETERIZATION; FEMALE; HEART FAILURE; HEART RATE; KIDNEY; SHEEP; SYMPATHECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84929190774     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.440     Document Type: Article

References (49)

1. M. Weiss, M. Kenney, T. Musch, K. Patel, Modifications to central neural circuitry during heart failure, Acta Physiol. Scand. 177 (2003) 57-67.
2. G.J. Hasking, M.D. Esler, G.L. Jennings, D. Burton, J.A. Johns, P.I. Korner, Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity, Circulation 73 (1986) 615-621.
3. D.M. Kaye, J. Lefkovits, G.L. Jennings, P. Bergin, A. Broughton, M.D. Esler, Adverse consequences of high sympathetic nervous activity in the failing human heart, J. Am. Coll. Cardiol. 26 (1995) 1257-1263.
4. J. Kjekshus, K. Swedberg, S. Snapinn, Effects of enalapril on long-term mortality in severe congestive heart failure. CONSENSUS Trial Group, Am. J. Cardiol. 69 (1992) 103-107.
5. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees, Circulation 90 (1994) 1765-1773.
6. M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown Jr., T.E. Cuddy, et al., Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction aftermyocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators, N. Engl. J. Med. 327 (1992) 669-677.
7. M. Tonkon, N. Awan, I. Niazi, P. Hanley, L. Baruch, R.A. Wolf, et al., A study of the efficacy and safety of irbesartan in combination with conventional therapy, including ACE inhibitors, in heart failure. Irbesartan Heart Failure Group, Int. J. Clin. Pract. 54 (2000) 11-14.
8. M. Ruzicka, J.S. Floras, A.J. McReynolds, E. Coletta, H. Haddad, R. Davies, et al., Do high doses of AT(1)-receptor blockers attenuate central sympathetic outflow in humans with chronic heart failure? Clin. Sci. (Lond.) 124 (2013) 589-595.
9. S. Bangalore, S. Kumar, F.H. Messerli,When conventional heart failure therapy is not enough: Angiotensin receptor blocker, direct renin inhibitor, or aldosterone antagonist? Congest. Heart Fail. 19 (2013) 107-115.
10. M.D. Esler, H. Krum, P.A. Sobotka, M.P. Schlaich, R.E. Schmieder, M. Bohm, Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial, Lancet 376 (2010) 1903-1909.
11. H. Krum, M. Schlaich, R.Whitbourn, P.A. Sobotka, J. Sadowski, K. Bartus, et al., Catheterbased renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study, Lancet 373 (2009) 1275-1281.
12. G.F. DiBona, U.C. Kopp, Neural control of renal function, Physiol. Rev. 77 (1997) 75-197.
13. R.E. Katholi, W.T. Woods, Afferent renal nerves and hypertension, Clin. Exp. Hypertens. A 9 (Suppl. 1) (1987) 211-226.
14. V.M. Campese, E. Kogosov, M. Koss, Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat, Am. J. Kidney Dis. 26 (1995) 861-865.
15. M.P. Schlaich, P.A. Sobotka, H. Krum, E. Lambert, M.D. Esler, Renal sympatheticnerve ablation for uncontrolled hypertension, N. Engl. J. Med. 361 (2009) 932-934.
16. D. Hering, E.A. Lambert, P. Marusic, A.S. Walton, H. Krum, G.W. Lambert, et al., Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension, Hypertension 61 (2013) 457-464.
17. M. Ezzahti, A. Moelker, E.C. Friesema, N.A. van der Linde, G.P. Krestin, A.H. van den Meiracker, Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension, J. Hypertens. 32 (2014) 135-141.
18. D. Hering, P. Marusic, A.S. Walton, E.A. Lambert, H. Krum, K. Narkiewicz, et al., Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension, Hypertension 64 (2014) 118-124.
19. M. Petersson, P. Friberg, G. Eisenhofer, G. Lambert, B. Rundqvist, Long-termoutcome in relation to renal sympathetic activity in patients with chronic heart failure, Eur. Heart J. 26 (2005) 906-913.
20. J.E. Davies, C.H. Manisty, R. Petraco, A.J. Barron, B. Unsworth, J. Mayet, et al., First-inman safety evaluation of renal denervation for chronic systolic heart failure: Primary outcome from REACH-Pilot study, Int. J. Cardiol. 162 (2013) 189-192.
21. C. Ukena, A. Bauer, F. Mahfoud, J. Schreieck, H.R. Neuberger, C. Eick, et al., Renal sympathetic denervation for treatment of electrical storm: First-in-man experience, Clin. Res. Cardiol. 101 (2012) 63-67.
22. W.L.Verloop,M.M. Beeftink,A. Nap, M.L. Bots, B.K. Velthuis, Y.E.Appelman, et al., Renal denervation in heart failure with normal left ventricular ejection fraction. Rationale and design of the DIASTOLE (DenervatIon of the renAl Sympathetic nerves in hearT failure with nOrmal Lv Ejection fraction) trial, Eur. J. Heart Fail. 15 (2013) 1429-1437.
23. T. Nozawa, A. Igawa, N. Fujii, B. Kato, N. Yoshida, H. Asanoi, et al., Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats, Heart Vessels 16 (2002) 51-56.
24. J. Hu, Y. Li, W. Cheng, Z. Yang, F. Wang, P. Lv, et al., A comparison of the efficacy of surgical renal denervation and pharmacologic therapies in post-myocardial infarction heart failure, PLoS One 9 (2014) e96996.
25. J. Hu, Y. Yan, Q. Zhou, M. Ji, C. Niu, Y. Hou, et al., Effects of renal denervation on the development of post-myocardial infarction heart failure and cardiac autonomic nervous system in rats, Int. J. Cardiol. 172 (2014) e414-e416.
26. Z. Guo, Q. Zhao, H. Deng, Y. Tang, X. Wang, Z. Dai, et al., Renal sympathetic denervation attenuates the ventricular substrate and electrophysiological remodeling in dogs with pacing-induced heart failure, Int. J. Cardiol. 175 (2014) 185-186.
27. Q. Zhao, S. Yu, H. Huang, Y. Tang, J. Xiao, Z. Dai, et al., Effects of renal sympathetic denervation on the development of atrial fibrillation substrates in dogs with pacing-induced heart failure, Int. J. Cardiol. 168 (2013) 1672-1673.
28. S.C. Clayton, K.K. Haack, I.H. Zucker, Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure, Am. J. Physiol. Renal Physiol. 300 (2010) F31-F39.
29. A.M. Schiller, K.K. Haack, P.R. Pellegrino, P.L. Curry, I.H. Zucker, Unilateral renal denervation improves autonomic balance in conscious rabbits with chronic heart failure, Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 (2013) R886-R892.
30. G.F. DiBona, L.L. Sawin, Role of renal nerves in sodium retention of cirrhosis and congestive heart failure, Am. J. Physiol. 260 (1991) R298-R305.
31. D. Villarreal, R.H. Freeman, R.A. Johnson, J.C. Simmons, Effects of renal denervation on postprandial sodium excretion in experimental heart failure, Am. J. Physiol. 266 (1994) R1599-R1604.
32. R. Ramchandra, S.G. Hood, R. Frithiof, C.N. May, Discharge properties of cardiac and renal sympathetic nerves and their impaired responses to changes in blood volume in heart failure, Am. J. Physiol. Regul. Integr. Comp. Physiol. 297 (2009) R665-R674.
33. A. Watson, S. Hood, R. Ramchandra, R. McAllen, C. May, Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex, Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H798-H804.
34. P.J. Dunn, E.A. Espiner, Outpatient screening tests for primary aldosteronism, Aust. NZ J. Med. 6 (1976) 131-135.
35. G.W. Lambert, I.H. Jonsdottir, Influence of voluntary exercise on hypothalamic norepinephrine, J. Appl. Physiol. 85 (1998) 962-966.
36. J. Fox, The R Commander: A basic statistics graphical user interface to R, J. Stat. Softw. 14 (2005) 1-42.
37. R Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2013.
38. S. Oparil, W. Sripairojthikoon, J.M. Wyss, The renal afferent nerves in the pathogenesis of hypertension, Can. J. Physiol. Pharmacol. 65 (1987) 1548-1558.
39. J.K. Phillips, Pathogenesis of hypertension in renal failure: Role of the sympathetic nervous system and renal afferents, Clin. Exp. Pharmacol. Physiol. 32 (2005) 415-418.
40. U.C. Kopp, M.Z. Cicha, L.A. Smith, Impaired responsiveness of renal mechanosensory nerves in heart failure: Role of endogenous angiotensin, Am. J. Physiol. Regul. Integr. Comp. Physiol. 284 (2003) R116-R124.
41. U.C. Kopp, M.Z. Cicha, S.Y. Jones, Activation of endothelin A receptors contributes to impaired responsiveness of renal mechanosensory nerves in congestive heart failure, Can. J. Physiol. Pharmacol. 88 (2010) 622-629.
42. H. Ueda, Y. Uchida, K. Kamisaka, Mechanism of the reflex depressor effect by the kidney in dog, Jpn. Heart J. 8 (1967) 597-606.
43. G. Recordati, S. Genovesi, D. Cerati, Renorenal reflexes in the rat elicited upon stimulation of renal chemoreceptors, J. Auton. Nerv. Syst. 6 (1982) 127-142.
44. N. Ashton, C.G. Clarke, D.E. Eddy, F.V. Swift,Mechanisms involved in the activation of ischemically sensitive, afferent renal nerve mediated reflex increases in hind-limb vascular resistance in the anesthetized rabbit, Can. J. Physiol. Pharmacol. 72 (1994) 637-643.
45. Q.M. Dai, Y. Fen, J. Lu, G.S. Ma, Efficacy of regional renal nerve blockade in patients with chronic refractory heart failure, Chin. Med. J. 126 (2013) 1076-1080.
46. T. Oyama, K. Taniguchi, T. Jin, T. Satone, T. Kudo, Effects of anaesthesia and surgery on plasma aldosterone concentration and renin activity in man, Br. J. Anaesth. 51 (1979) 747-752.
47. M. Sagy, M. Aladjem, A. Shem-Tov, A. Eshkol, S. Orda, J. Hegesh, et al., The renal effects of radiocontrast administration during cardioangiography in two different groups with congenital heart disease, Eur. J. Pediatr. 141 (1984) 236-239.
48. R. Ramchandra, A.M. Watson, S.G. Hood, C.N. May, Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure, Am. J. Physiol. Regul. Integr. Comp. Physiol. 298 (2010) R1056-R1060.
49. M.E. Dibner-Dunlap, M.L. Smith, T. Kinugawa, M.D. Thames, Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure, J. Am. Coll. Cardiol. 27 (1996) 358-364.